Find Academic Supervisors

Cecilia TrevisiView profile

Research Fellow

• Global Health
• Biostatistics
• Epidemiology
• +3 more

Cecilia Trevisi is a Research Fellow in the Department of Global Health and Social Medicine at Harvard Medical School. She is currently enrolled in the Statistics and Data Science track of the Master’s program in Statistics and Economics at the University of Milano-Bicocca, where she also earned her Bachelor's degree in Statistics and Information Management. Her research focuses on applying advanced statistical methodologies to analyze causal relationships between healthcare interventions and clinical outcomes, particularly in the context of emerging regimens for drug-resistant tuberculosis. Education: Bachelor's degree in Statistics and Information Management, University of Milano-Bicocca Master’s in Statistics and Economics (Statistics and Data Science track), University of Milano-Bicocca Research Interests: Cecilia’s work integrates statistical analysis with global health challenges, emphasizing the application of graph-based dependence structures and causal inference methods. Her current projects address critical gaps in understanding treatment efficacy for drug-resistant tuberculosis, leveraging interdisciplinary approaches to improve clinical outcomes. Advising & Grants: No specific grants or advising roles are listed in the provided information. Labs/Teams: Affiliated with the Department of Global Health and Social Medicine at Harvard Medical School, contributing to its broader initiatives in global health equity and evidence-based interventions.

Courtney M. YuenView profile

Assistant Professor

• Global Health
• Epidemiology
• Infectious Diseases
• +3 more

Courtney M. Yuen is an Assistant Professor of Global Health and Social Medicine at Harvard Medical School and an Associate Professor of Medicine at Brigham and Women's Hospital. She specializes in global health epidemiology, particularly focusing on childhood drug-resistant tuberculosis and its public health implications. Previously, she worked at the U.S. Centers for Disease Control and Prevention (CDC) in the Division of Tuberculosis Elimination. Her research emphasizes improving tuberculosis prevention and treatment strategies, including contact investigations and preventive therapy implementation. She collaborates with programs in Kenya and Peru to evaluate interventions aimed at reducing tuberculosis burden. Dr. Yuen’s work bridges clinical practice, epidemiological research, and global health policy. No specific scientific awards, grants, or advising records are disclosed in the provided text. Her ongoing projects include global health equity initiatives and tuberculosis case-finding strategies in resource-limited settings.

Katsuhiko MurakamiView profile

Professor

• Structural Biology
• Gene Regulation
• RNA Biology
• +5 more

Katsuhiko Murakami is a Professor in the Department of Biochemistry and Molecular Biology at Pennsylvania State University. He holds affiliations with the Huck Institutes of the Life Sciences and the Center for Structural Biology. His research focuses on understanding gene expression mechanisms, particularly RNA polymerase structures and transcription regulation in bacteria, archaea, and bacteriophages. He employs X-ray crystallography and cryo-EM techniques. Recent work includes studies on SARS-CoV-2 proteins and drug development for tuberculosis. Dr. Murakami earned his Ph.D. from the National Institute of Genetics in Japan (1997) and completed postdoctoral training at Rockefeller University (1998–2003). He joined Penn State in 2003 and became a full Professor in 2015. He has held prestigious awards including the Pew Scholars Program (2005–2009) and AAAS Fellowship (2020). His lab investigates transcription mechanisms, structural biology, and infectious diseases. Key areas include RNA polymerase inhibitor design and SARS-CoV-2 protease studies. He advises graduate students like Natalie Smith and George Fordjour, and collaborates on drug development projects. Dr. Murakami leads the Murakami Lab and directs the Center for Structural Biology. His work bridges structural biology with functional genomics, contributing to both basic science and applied medical research.

Martin W. BloemView profile

Professor

• Nutrition
• Food Systems
• Food Security
• +7 more

Martin W. Bloem is a Professor at the Johns Hopkins Bloomberg School of Public Health, with primary affiliation in the Department of Environmental Health and Engineering and joint appointments in International Health and the Human Nutrition Center. He also serves as the Director of the Johns Hopkins Center for a Livable Future (CLF), a leading interdisciplinary research center focused on food systems, environmental sustainability, and public health. Department: Environmental Health and Engineering School: Bloomberg School of Public Health Institution: Johns Hopkins University Leadership: Director, Johns Hopkins Center for a Livable Future Bloem holds an MD from the University of Utrecht and a PhD from the University of Maastricht. His academic career has been dedicated to improving public health and nutrition programs in low- and middle-income countries through applied research. His work bridges clinical medicine, public health, and environmental science, with a strong emphasis on policy-relevant outcomes. His research interests include nutrition, food systems, food security, HIV/AIDS, micronutrient deficiencies, and the intersection of climate change with health and agriculture. He has led and contributed to numerous studies on the role of nutrition in disease prevention and treatment adherence, particularly in resource-limited settings. His recent work explores sustainable diets, alternative proteins, and food systems innovation, reflecting a forward-looking approach to global health challenges. The trends in his recent publications (2023–2024) indicate a strong focus on sustainable food systems, climate change impacts, and the alignment of food production with public health goals. His research spans both high-income and low-income contexts, with a recurring emphasis on equity, accessibility, and policy translation. He frequently collaborates with international teams and contributes to high-impact journals such as PNAS and Frontiers in Sustainable Food Systems . Bloem has made significant contributions to the field through his editorial work, including the widely used textbook Nutrition and Health in a Developing World . While specific scientific awards are not listed in the provided text, his leadership roles, publication record, and institutional affiliations reflect a distinguished academic career. He is actively involved in mentoring and advising, though specific student names are not mentioned. His research is supported by collaborations across disciplines and institutions, and he leads initiatives that integrate research, policy, and practice. As Director of CLF, he oversees a multidisciplinary team working on food system transformation, urban agriculture, and environmental justice. Bloem is based at 615 N. Wolfe Street, Baltimore, MD, and can be reached at mbloem1@jhu.edu. His ongoing research activity, recent publications, and leadership roles confirm his status as an active and influential figure in global public health.

Līga KukšaView profile

Researcher

• Clinical Medicine
• Tuberculosis Treatment
• Drug Resistance
• +3 more

Līga Kukša is a researcher specializing in clinical medicine and tuberculosis treatment. Her work focuses on drug-resistant tuberculosis, chronic obstructive pulmonary disease, and pharmacological interventions in Latvia. She collaborates with European institutions like the Tuberculosis Network European Trials group (TBnet) and contributes to global health initiatives.

• Tuberculosis
• Antimicrobial Resistance (AMR)
• Diagnostic Methods
• +5 more

Francis Drobniewski is the Chair in Global Health and Tuberculosis at Imperial College London's Faculty of Medicine, Department of Infectious Disease. He holds honorary professorships at Queen Mary University of London, King's College London, and Bournemouth University. His roles include leadership in the NHS, WHO, and global health initiatives. He is a Fellow of the American Academy of Microbiology and ESCMID, and has served on multiple international committees addressing AMR and TB/HIV. Education: MA (Trinity College Dublin), MB BS (St Bartholomew's Medical College), PhD (University of Cambridge), MSc/DTM&H (London School of Hygiene & Tropical Medicine). Certifications include Good Clinical Practice (GCP) and leadership training. Research focuses on tuberculosis diagnostics, AMR mechanisms, and public health strategies for respiratory diseases. Key interests include TB/HIV co-infection dynamics, drug resistance evolution, and vaccine hesitancy mitigation. He leads projects funded by EU Horizon programs, NIHR, and Wellcome Trust. His work on the VAROT Study and EuCARE consortium addresses ototoxicity from aminoglycosides and SARS-CoV-2 variant impacts. He pioneered the UK National Mycobacterium Reference Laboratory and chairs WHO's European Lab Initiative. Awards: Fellowships in microbiology and ESCMID membership. Recognized for contributions to TB diagnostics and global health policy. Advising/Grants: Principal Investigator for EU-funded projects. Collaborates with industry on diagnostic development. Leads training programs in Eastern Europe and Ukraine. Directs Health Sciences Research Ltd, supporting early-career scientists. Labs: Former Director of UK's National TB Reference Lab (1996–2015). Currently advises NHS Dorset as a part-time Consultant Microbiologist. Research integrates clinical, social, and genetic data from longitudinal cohorts in Europe and LMICs.

• Pediatric Infectious Diseases
• Immunology
• Tuberculosis (TB) Research
• +5 more

Elizabeth Whittaker is a Professor of Practice in Paediatric Infectious Diseases and Immunology at Imperial College London's Faculty of Medicine, with clinical roles as a Consultant in Paediatric Infectious Diseases at St Mary's Hospital. She leads research and clinical initiatives in high-consequence infectious diseases (HCIDs), paediatric TB, and post-COVID-19 conditions. Key roles include National Clinical Lead for HCIDs in children (NHSE), Director of Research at West London Children's Healthcare (WLCH), and co-lead for HCID at Imperial College Healthcare NHS Trust. Affiliations: Centre for Paediatrics and Child Health (PaeCH), Vaccine Research Network, British Paediatric Allergy Infection and Immunity Group (BPAIIG), and PTBNET. Educations: MB BAO BCH (Trinity College Dublin, 2002), PhD in Immune responses to mycobacteria (Imperial College London, 2013), DTM&H (Gorgas Course, 2009). Her research focuses on infant immune development, TB susceptibility, and vaccine hesitancy, with emphasis on global collaboration. She leads projects like the Teen TB cohort study and contributes to WHO guidelines on paediatric TB. Her work addresses viral co-infections, genetic predisposition to severe infections, and long-term outcomes of emerging diseases like monkeypox and MIS-C. Publications highlight her expertise in post-COVID-19 syndrome, HCID management, and vaccination policy. Awards include the Bruno Orsi Medal for research excellence. She chairs national committees on TB, HCIDs, and vaccine hesitancy, advocating for integrated clinical-research pathways in child health. Grants & Funding: Wellcome Trust (PhD), multiple NHS research grants, and international collaborations through the IMPRINT and INVAR networks. Labs/Teams: Leads the Imperial College Paediatric Infectious Diseases Research Group and collaborates with SATVI (South Africa) on TB research.

Lukáš KoberView profile

Assistant Professor

• Public Health
• Nursing
• Infectious Disease Control
• +3 more

PhDr. Lukáš Kober PhD., MPH is an Assistant Professor at the Department of Nursing, Faculty of Health, Catholic University in Ružomberok. He also serves as Director of the Slovak Chamber of Nurses and Midwives (SKSaPA) Office since 2020 and is a member of SKSaPA's Council and Presidium. His career spans nursing practice, academic roles, and public health advocacy. Education: Holds a PhD in Nursing, MPH in Public Health Management, and multiple specialized certifications from institutions like Trnava University and Slovak Medical University. Employment History: Over 15 years of experience including roles as Advanced Practice Registered Nurse at the National Institute of Tuberculosis (2004–2020), professional representative for Home Nursing Agencies, and lecturer in nursing education. Research interests focus on tuberculosis epidemiology, public health policy, infection control, and ethical aspects of nursing practice. He has led projects developing textbooks on infection prevention and rehabilitation procedures post-surgery. His work emphasizes healthcare workforce well-being and pandemic preparedness. Notable publications include studies on tuberculosis trends in Slovakia, nurse workload management during the pandemic, and ethical frameworks in palliative care. Awards include the prestigious 'White Heart' recognition for nursing excellence in 2016 and 2018. Current projects involve advancing nursing education standards and advocating for policies addressing healthcare worker mental health. He is actively involved in editorial roles for nursing journals and national health working groups.

Gail MatthewsView profile

Professor

• Infectious Diseases
• HIV/AIDS
• Viral Hepatitis
• +5 more

Professor Gail Matthews is a leading Infectious Diseases Physician at The Kirby Institute , University of New South Wales, and Head of Infectious Diseases at St Vincent’s Hospital, Sydney . As a UNSW Scientia Fellow and NHMRC Career Development Fellow, her work focuses on HIV/viral hepatitis co-infection and long-term sequelae of COVID-19 . Research Interests : HIV, hepatitis B/C, antiviral resistance, clinical trials, immunology Awards : NHMRC Career Development Fellowships (Level 1, 2013; Level 2, 2019), UNSW Scientia Fellow (2019) Publications : Over 326 journal articles on topics including HCV reinfection , HIV/HBV coinfection , long-term SARS-CoV-2 outcomes , and infections in people who inject drugs . Email : gmatthews@kirby.unsw.edu.au

• Infectious Diseases
• Epidemiology
• Public Health
• +7 more

Dr. Win Min Han is an infectious disease researcher at the University of New South Wales' Kirby Institute, with additional affiliations as an Investigator with the AIDS Clinical Trial Group Network and Affiliated Researcher at Chulalongkorn University, Thailand. He holds MD, MSc, and PhD qualifications with specialized training in clinical epidemiology and virology. His research focuses on HIV-related comorbidities in aging populations, viral hepatitis co-infections, and epidemiological patterns of infectious diseases in vulnerable groups. Primary interests include: Pathophysiology of aging with HIV Clinical trial design for co-infections Cancer epidemiology in immunocompromised patients Metabolic complications of long-term ART Public health interventions for key populations Publication analysis reveals consistent focus on longitudinal outcomes of HIV management, with recent work emphasizing geriatric syndromes, metabolic complications, and innovative treatment monitoring approaches. His 60+ publications demonstrate methodological expertise in cohort studies, clinical trials, and predictive modeling. Awards & Honors: 2024: IAS/ANRS Lange/van Tongeren Prize, CROI New Investigator Scholarship 2023: ACTG's International HIV Investigator Mentorship, CROI Scholarship 2021: APACC Young Investigator Scholarship 2020: AIDS 2020 International Scholarship 2019: Scientia PhD Scholarship (2019-2023) 2018: Multiple conference scholarships including CROI and International AIDS Conference 2017: Triple scholarships from International AIDS Society As an active member of the AIDS Clinical Trial Group Network, he contributes to multicenter studies on HIV comorbidities. His international collaborations span Thailand, Australia, and global research consortia.

Benjamin HegartyView profile

Research Fellow

• Medical Anthropology
• Gender and Sexuality Studies
• Global Health
• +3 more

Benjamin Hegarty is a Senior Research Fellow in the Asia and Pacific Health Program at the Kirby Institute, UNSW Sydney, and a Research Affiliate at the School of Anthropology and Museum Ethnography, University of Oxford. He holds a PhD from the Australian National University (ANU), an MA from Monash University, and a BA from Griffith University. His research bridges medical anthropology, transgender studies, and queer theory, focusing on health inequities and gender norms, particularly in Indonesia and Papua New Guinea. He leads projects on transgender rights, HIV/AIDS policy, and the intersection of health and human rights for marginalized populations. Key research interests include the anthropology of technology, gender citizenship, and the globalization of transgender knowledge. Notable achievements include authoring The Made-Up State: Technology, Trans Femininity, and Citizenship in Indonesia (2022), which won the 2023 Anne Bolin and Gilbert Herdt Book Prize. He has also received the 2018 Australian Anthropological Society PhD Thesis Prize and ANU Gender Institute recognition. Current projects include a French Institutes for Advanced Studies Fellowship (2024–2025) exploring viral symbiosis and multispecies anthropology. Hegarty’s work appears in journals like Medical Anthropology , American Ethnologist , and Global Public Health . He is affiliated with initiatives such as the Australian Human Rights Institute and the Center for HIV AIDS Research at Atma Jaya Catholic University.

• Pulmonary Disease
• Epidemiology
• Air Pollution
• +3 more

Professor Guy Marks is a Conjoint Professor in the School of Clinical Medicine within the Faculty of Medicine & Health at the University of New South Wales. A distinguished respiratory physician, epidemiologist, and public health physician, he has led the Respiratory and Environmental Epidemiology group at the Woolcock Institute of Medical Research since 1997. His work bridges clinical practice, epidemiological research, and public health policy with a focus on improving lung health globally. Professor Marks' educational background includes: Bachelor of Medical Science and Bachelor of Medicine/Bachelor of Surgery (BMedSc MB BS) from the University of New South Wales PhD from the University of Sydney Membership in the Royal College of Physicians (MRCP) Fellowship of the Royal Australasian College of Physicians (FRACP) Fellowship of the Australasian Faculty of Public Health Medicine (FAFPHM) Fellowship of the Australian Academy of Health and Medical Sciences (FAHMS) Professor Marks' research program centers on lung health with specific emphasis on airways diseases, air pollution, and tuberculosis. His work spans epidemiological studies, clinical trials, and public health interventions aimed at improving respiratory health outcomes. He has a strong commitment to capacity building for lung health research, particularly in resource-limited settings. His research has significantly contributed to understanding the impact of environmental factors on respiratory diseases and developing effective strategies for tuberculosis control. Analysis of Professor Marks' recent publications (2023-2025) reveals a continued strong focus on tuberculosis epidemiology and control, air pollution health effects, and respiratory disease management. His work increasingly incorporates advanced methodologies including machine learning applications for tuberculosis detection, detailed air pollution modeling, and economic evaluations of public health interventions. Much of his research maintains a strong international perspective with significant collaborations across the Asia-Pacific region, particularly in Vietnam. Professor Marks is an active member of several professional societies: International Union Against Tuberculosis and Lung Disease Thoracic Society of Australia and New Zealand Australasian Epidemiological Association While specific details about his advising activities and grant funding are not provided in the available information, Professor Marks' extensive publication record and leadership of the Respiratory and Environmental Epidemiology group at the Woolcock Institute suggest substantial experience mentoring students and securing research funding. His work on tuberculosis prevention trials and air pollution health effects likely involves significant grant support. Professor Marks leads the Respiratory and Environmental Epidemiology group at the Woolcock Institute of Medical Research, which has been active since 1997. This research team focuses on population-level studies of respiratory diseases with particular expertise in tuberculosis epidemiology, air pollution health effects, and asthma/COPD management. The group maintains strong international collaborations, especially with researchers in Vietnam and other Asia-Pacific countries, reflecting Professor Marks' commitment to global lung health research and capacity building.

Christopher C. WhalenView profile

Professor

• Infectious Disease Epidemiology
• Global Health
• HIV/AIDS Research
• +3 more

Christopher C. Whalen is a Professor in the Department of Epidemiology & Biostatistics at the University of Georgia's College of Public Health , with affiliations to the Global Health Institute. He holds the Karen and Jim Holbrook Distinguished Professorship in Global Health and is a UGA Distinguished Research Professor. His research focuses on reducing mortality from infectious diseases, particularly tuberculosis (TB) and HIV in Sub-Saharan Africa, with emphasis on Uganda. He leads studies on TB control methods, HIV-TB coinfection mechanisms, and clinical care improvements. Since 1993, he has secured continuous federal grant funding for projects including household contacts studies, social network analyses, cohort studies, and clinical trials in Africa. Key Achievements: Trained over 100 graduate students via the AIDS Training and Research Program in Uganda since 1992. Developed capacity in immunology, microbiology, and data sciences in Africa. Expert in study design, causal inference, and analysis of large datasets. Advising & Grants: Serves as Principal Investigator (PI) for long-term training and research programs. Office hours: Tuesdays 11:00 a.m.–3:00 p.m. or by appointment.

Mukhlesur RahmanView profile

Associate Professor

• Pharmaceutical Chemistry
• Natural Product Chemistry
• Drug Discovery
• +5 more

Dr. Mukhlesur Rahman is an Associate Professor in Pharmaceutical and Natural Product Chemistry at the University of East London (UEL), leading the Medicines Research Group since 2020. He is also the Subject Area Lead for Drug and Chemical Sciences. He developed the BSc and MSc Pharmaceutical Science programs at UEL between 2012-2019. Education: BPharm (Hons) with First Class, MPharm with First Class, PhD. Research Interests: Bioassay-guided isolation of anti-infective compounds from plants and microbes, synthesis of bioactive natural products, NMR spectroscopy in drug discovery, ethnopharmacology, and applications of HPLC/LCMS for herbal medicine quality control. Publications: Over 30 peer-reviewed articles, book chapters, and editorials focusing on antimicrobial natural products, drug discovery, and computational phytochemistry. Recent work includes studies on anti-MRSA compounds from Citrus grandis and Ruta chalepensis, as well as synthetic drug candidates for tuberculosis and leprosy. Labs/Teams: Leads the Medicines Research Group, collaborating on drug discovery projects involving plant-derived compounds and synthetic drug design.

Yeon Soo BaikView profile

Researcher

• Epidemiology
• Tuberculosis Research
• HIV/AIDS Research
• +5 more

Yeon Soo Baik, PhD is an Assistant Scientist in the Department of International Health at Johns Hopkins Bloomberg School of Public Health, specializing in epidemiology with a focus on tuberculosis and HIV research. Their work spans multiple international settings including Uganda, South Africa, Botswana, and Bangladesh, addressing critical questions in infectious disease control and public health implementation. Dr. Baik completed their PhD at the University of California Los Angeles in 2019, with subsequent postdoctoral training in epidemiology. Their research expertise encompasses epidemiologic methods, translational epidemiology, molecular epidemiology, transmission and prediction modeling, longitudinal cohort analysis, and health economics specifically applied to TB/HIV research. Dr. Baik's research program demonstrates strong focus on implementation science, with numerous projects examining tuberculosis self-testing strategies in Peru, diagnostic accuracy of GeneXpert Ultra testing in South Africa, validation of clinical risk scores for early TB management in Uganda, and evaluation of short-course tuberculosis preventive therapy delivery options. They have also investigated Korea's contribution to global tuberculosis eradication efforts. Analysis of their recent publications reveals consistent focus on tuberculosis prevention and treatment among people living with HIV, with particular attention to implementation barriers, cost considerations, and patient preferences in resource-limited settings. Their work increasingly incorporates methodological approaches from health economics and behavioral science to address implementation challenges. Dr. Baik actively collaborates with researchers across multiple institutions and countries, with research output showing steady growth from 2018 to 2025. Their work has been cited in various contexts, including news outlets and social media, indicating broader impact beyond academic circles. Through their research, Dr. Baik has established expertise in quantitative epidemiology that extends beyond TB/HIV to include Chagas disease, respiratory and neurological diseases, and sexually transmitted infections, demonstrating methodological versatility in addressing diverse public health challenges.